Compliance
The Eighth Circuit just vacated the Federal Trade Commission’s 2024 “Click-to-Cancel” rule, but state laws and legacy FTC rules still impose cancellation obligations.
Discover how the Supreme Court’s ruling on an ADA case leaves uncertainty over class actions with uninjured members and potential exposure for employers.
Read about ProPublica’s lawsuit against the Food and Drug Administration (FDA) over drug safety transparency for generics made in overseas factories with records of violations.
Read how executive orders, political pressures, and shifting norms are converging, forcing compliance leaders to navigate risk with clarity.
The Mental Health Parity and Addiction Equity Act is currently paused, but core compliance obligations remain in effect. What does this mean for your team?
The Committee of Sponsoring Organizations of the Treadway Commission’s (COSO) Corporate Governance Framework redefines strategy as a core compliance responsibility, placing ethics and risk at the heart of value creation.
New guidance from the Food and Drug Administration (FDA) shows how Remote Regulatory Assessments (RRA) may reshape compliance under the Drug Supply Chain Security Act (DSCSA).
Understand the difference between Japan’s new AI bill, which charts a course for innovation, and the regulation-focused EU AI Act passed earlier this year.
Learn what general counsel should do to ensure their organizations are well-positioned to navigate Trump’s tariffs and the uncertainty surrounding them.
Read how Texas’s TRAIGA lifts responsible AI governance with intent‑based liability, safe harbors, and a first‑in‑nation sandbox, giving firms 18 months to adapt.
Daily Updates
Sign up for our free daily newsletter for the latest news and business legal developments.
